LIQUID BIOPSY IS REVOLUTIONIZING CANCER TREATMENT. NRICHDX EMPOWERS THAT REVOLUTION.
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 19 Feb 2026)
What this means for you
Registered since 03 Nov 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88250571
- Registration number
- 6190469
- Mark type
- Stylized text
- Filed
- 04 Jan 2019
- Published for opposition
- 07 May 2019
- Registered
- 03 Nov 2020
- Attorney of record
- Matthew A. Newboles
Goods and services
- Class 010 — Medical apparatus: cell culture and cancer diagnostics tests, namely, liquid biopsy testing systems consisting of a specimen chamber assembly and magnetic materials used to sequester target analytes of interest within a liquid sample for isolation and characterization
Owner
- WAVESENSE, INC., IRVINE, CA, US
- WAVESENSE, INC., IRVINE, CA, US
- WAVESENSE, INC., IRVINE, CA, US
Prosecution history
- 19 Feb 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 19 Feb 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 19 Feb 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Nov 2025 — TEAS SECTION 8 & 15 RECEIVED
- 03 Nov 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 Nov 2020 — REGISTERED-PRINCIPAL REGISTER
- 02 Oct 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Oct 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Sept 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Sept 2020 — USE AMENDMENT FILED
- 18 Sept 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Sept 2020 — TEAS STATEMENT OF USE RECEIVED
- 04 Jul 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jul 2020 — SOU EXTENSION 2 GRANTED
- 02 Jul 2020 — SOU EXTENSION 2 FILED